Akebia Therapeutics Inc (AKBA)

08:09 AM

Akebia Therapeutics to Present at Upcoming Investor Conferences - The Manila Times

08:09 AM

08:00 AM

Akebia (NASDAQ: AKBA) to present at Guggenheim and Jefferies in November - Stock Titan

08:00 AM

06:04 AM

Is Akebia Therapeutics Inc. stock a safe investment in uncertain markets2025 Geopolitical Influence & AI Driven Price Predictions - newser.com

06:04 AM

05:55 AM

Revenues Working Against Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) Share Price Following 25% Dive - simplywall.st

05:55 AM

05:11 AM

Tools to assess Akebia Therapeutics Inc.’s risk profileJuly 2025 Market Mood & Risk Managed Investment Strategies - newser.com

05:11 AM

04:06 AM

Live market analysis of Akebia Therapeutics Inc.Market Rally & Real-Time Volume Analysis Alerts - newser.com

04:06 AM

04:04 AM

Will earnings trigger a reversal in Akebia Therapeutics Inc.July 2025 Fed Impact & Safe Swing Trade Setup Alerts - newser.com

04:04 AM

01:45 AM

Why Akebia Therapeutics Inc. (AX9) stock attracts wealthy investorsOil Prices & Risk Managed Investment Signals - newser.com

01:45 AM

01:14 AM

Analyzing Akebia Therapeutics Inc. with risk reward ratio chartsJuly 2025 Trade Ideas & Safe Capital Growth Plans - newser.com

01:14 AM

Nov 03, 2025

Akebia Therapeutics reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener

Nov 03, 2025

Nov 03, 2025

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail

Nov 03, 2025

Nov 03, 2025

Akebia (NASDAQ: AKBA) grants inducement options to new hires at $2.21 for 51,825 shares - Stock Titan

Nov 03, 2025

Nov 03, 2025

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Looks Inexpensive But Perhaps Not Attractive Enough - 富途牛牛

Nov 03, 2025

Nov 03, 2025

Levi & Korsinsky Investigates Akebia Therapeutics, Inc. (AKBA) Over Potential Securities Fraud Allegations - ACCESS Newswire

Nov 03, 2025

Nov 03, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Akebia Therapeutics, Inc. (AKBA) And Encourages Stockholders to Connect - ACCESS Newswire

Nov 03, 2025

Nov 03, 2025

Akebia Therapeutics Securities Lawsuit Investigation - Claim Depot

Nov 03, 2025

Nov 03, 2025

Will Akebia Therapeutics Inc. stock benefit from sector rotation2025 Support & Resistance & Safe Entry Trade Signal Reports - newser.com

Nov 03, 2025

Nov 03, 2025

Why institutional investors increase stakes in Akebia Therapeutics Inc. (AX9) stockDip Buying & Long-Term Capital Growth Strategies - newser.com

Nov 03, 2025

Nov 03, 2025

How Akebia Therapeutics Inc. stock reacts to job market dataJuly 2025 Sentiment & Community Trade Idea Sharing - newser.com

Nov 03, 2025

Nov 03, 2025

How high can Akebia Therapeutics Inc. stock goQuarterly Portfolio Summary & Target Return Focused Picks - newser.com

Nov 03, 2025

Nov 03, 2025

What makes Akebia Therapeutics Inc. stock attractive to growth fundsCEO Change & Low Risk High Win Rate Picks - newser.com

Nov 03, 2025

Nov 03, 2025

Can Akebia Therapeutics Inc. (AX9) stock deliver strong annual returnsJuly 2025 Selloffs & Fast Entry and Exit Trade Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Akebia Therapeutics Inc. stock retracement – recovery analysisEarnings Miss & Daily Volume Surge Trade Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Will Akebia Therapeutics Inc. (AX9) stock profit from AI boomForecast Cut & Stock Portfolio Risk Control - newser.com

Nov 03, 2025

Nov 03, 2025

Q3 EPS Estimate for Akebia Therapeutics Increased by Analyst - MarketBeat

Nov 03, 2025

Nov 02, 2025

How rising interest rates impact Akebia Therapeutics Inc. stockJuly 2025 Price Swings & Verified Momentum Stock Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

How strong dollar benefits Akebia Therapeutics Inc. (AX9) stockWeekly Stock Recap & Scalable Portfolio Growth Ideas - newser.com

Nov 02, 2025

Nov 02, 2025

Wall Street Zen Upgrades Akebia Therapeutics (NASDAQ:AKBA) to "Strong-Buy" - MarketBeat

Nov 02, 2025

Nov 01, 2025

Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Akebia Therapeutics, Inc. (AKBA) - ACCESS Newswire

Nov 01, 2025

Nov 01, 2025

HC Wainwright Issues Pessimistic Forecast for AKBA Earnings - MarketBeat

Nov 01, 2025

Nov 01, 2025

Is Akebia Therapeutics Inc. (AX9) stock undervalued at current priceJuly 2025 Volume & Risk Managed Investment Signals - newser.com

Nov 01, 2025

Nov 01, 2025

Can Akebia Therapeutics Inc. stock sustain revenue growthJuly 2025 Macro Moves & Low Risk Entry Point Guides - newser.com

Nov 01, 2025

Oct 31, 2025

Is Akebia Therapeutics Inc. (AX9) stock attractive for growth fundsJuly 2025 Institutional & Safe Investment Capital Preservation Plans - newser.com

Oct 31, 2025

Oct 31, 2025

Akebia Therapeutics (NASDAQ:AKBA) Stock Price Up 7.4%Here's Why - MarketBeat

Oct 31, 2025

Oct 31, 2025

Levi & Korsinsky Launches Fraud Investigation on Behalf of Akebia Therapeutics, Inc. (AKBA) Shareholders - ACCESS Newswire

Oct 31, 2025

Oct 31, 2025

Akebia Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights - ADVFN

Oct 31, 2025

Oct 31, 2025

Akebia Therapeutics (NASDAQ:AKBA) Price Target Lowered to $6.00 at HC Wainwright - MarketBeat

Oct 31, 2025

Oct 31, 2025

Akebia plummets as it abandons Vafseo for non-dialysis patients - MSN

Oct 31, 2025

Oct 31, 2025

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Tectonic Therapeutic (TECX) and Akebia Therapeutics (AKBA) - The Globe and Mail

Oct 31, 2025